News | Radiation Therapy | September 02, 2015

Varian Launches Developer Cloud to Foster Next-Generation Cancer Treatment Technologies

Part of OncoPeer online forum, toolkit features applications and information to accelerate development of new techniques and processes

Varian, Developer Cloud, OncoPeer online forum, next-generation cancer treatment technologies

September 2, 2015 — Varian Medical Systems has added a new cloud-based toolkit to the company's OncoPeer interactive online forum, making development tools available for research that has the potential to lead to next-generation cancer treatment technologies.

Varian's new Developer Cloud houses digital tools like information about TrueBeam Developer Mode, an optional non-clinical development tool, and cloud-based applications for managing Developer Mode and simulating treatments. It is part of the company's overall objective to empower research-oriented clinical teams to accelerate the development of new treatment techniques and processes designed to improve outcomes for cancer patients.

In a separate development, the OncoPeer online forum — first launched last March in select geographic areas — is now accessible to Varian customers worldwide. Since March, users have established discussion groups on topics like oncology analytics, knowledge-based treatment planning, treatment planning using Eclipse software and the physics of radiotherapy. One discussion group focuses on how to use Varian's Aria information system to manage a medical oncology department. Other groups share information about Varian treatment delivery platforms.

Varian held an online seminar about Navigating OncoPeer last May. Interested clinicians can view a replay of the webcast.

For more information:

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.